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Abstract
Background: HIV and HIV-TB co-infection are slowly increasing in Indonesia. WHO recommends
HIV testing among TB patients as a key response to the dual HIV-TB epidemic. Concerns over
potential negative impacts to TB control and lack of operational clarity have hindered progress. We
investigated the barriers and opportunities for introducing HIV testing perceived by TB patients
and providers in Jogjakarta, Indonesia.
Methods: We offered Voluntary Counselling and Testing (VCT) to TB patients in parallel to a HIV
prevalence survey. We conducted in-depth interviews with 33 TB patients, 3 specialist physicians
and 3 disease control managers. We also conducted 4 Focus Group Discussions (FGDs) with
nurses. All interviews and FGDs were recorded and data analysis was supported by the QSR N6®
software.
Results: Patients' and providers' knowledge regarding HIV was poor. The main barriers perceived
by patients were: burden for accessing VCT and fear of knowing the test results. Stigma caused
concerns among providers, but did not play much role in patients' attitude towards VCT. The main
barriers perceived by providers were communication, patients feeling offended, stigmatization and
additional burden.
Conclusion: Introduction of HIV testing among TB patients in Indonesia should be accompanied
by patient and provider education as well as providing conditions for effective communication.
Introduction
Indonesia is critical to the global tuberculosis (TB) control
efforts and increasingly important in the global HIV con-
trol efforts. The country ranks third in the world for TB
burden [1]. The number of reported AIDS cases has
increased by 15 fold in the past ten years [2]. The rapid
increase of new HIV infections in Indonesia makes the
epidemic one of the fastest growing in Asia, even though
the aggregate national prevalence is as low as 0.16% [3].
By the end of 2007, there were 296 Voluntary Counselling
and Testing (VCT) clinics throughout Indonesia, in addi-
tion to 153 hospitals which provide free antiretroviral
treatment [3]. Patients with HIV-TB co-infection are
appearing in hospitals and jails across several provinces
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and TB is a leading opportunistic infection among AIDS
patients [4]. These trends suggest a potential of a dual
HIV-TB epidemic, which many other developing coun-
tries, particularly in Sub-Saharan Africa are already facing.
WHO Interim Policy on HIV-TB recommends HIV testing
among TB patients as an entry point for integrated HIV-TB
care and surveillance [5]. However, scaling-up of this pol-
icy has been lagging [6]. Concerns over stigmatization
which may generate TB patients unwillingness to use HIV
associated services (with potential negative impact on TB
case detection) and lack of detailed operational guidelines
are among the important barriers [6,7].
Additionally, there is an ethical debate surrounding HIV
testing among TB patients, particularly with regard to the
unlinked anonymous testing method, in view of the
improved prospects for HIV/AIDS treatment [8]. This led
to linked confidential testing through an 'opt in'
approach, which has been offered in Voluntary Counsel-
ling and Testing (VCT) centres [9]. More recently, WHO
encouraged the adoption of provider-initiated linked con-
fidential testing and counselling (PITC) [10]. In contrast
to VCT, PITC is based on an 'opt out' approach in which
the clinician initiates counselling when an individual is
seeking medical care with signs or symptoms compatible
with HIV infection [9].
Ultimately, decisions about how to implement HIV test-
ing in TB patients, should be guided by an understanding
of issues surrounding HIV testing among TB patients from
the local stakeholders' perspectives [11]. Studies on
groups other than TB patients suggest that knowledge, fear
and access may constitute important barriers to HIV test-
ing [12-14]. This study aimed to shed light on the issue
through investigating the barriers for introducing HIV
testing perceived by TB patients and providers in Jogja-
karta, Indonesia.
Method
Study context
Jogjakarta province is located in the central part of Java
island. It is divided into five districts, has 3.2 million
inhabitants and covers an area of 3,185 square km. The
province's primary care network consists of around 650
private practices and 117 public community health cen-
tres staffed with doctors, midwives and nurses. These first
line services are backed up by 9 public hospitals and 24
private hospitals. The backbone of NTP's DOTS (Directly
Observed Treatment, Short-course) programme in Jogja-
karta province comprises a network of the 117 public
health centres, 5 chest clinics and 18 public and private
hospitals.
HIV prevalence among the general adult population in
Jogjakarta province is 0.15–2.0% [15]. It is much higher
among high-risk groups, e.g. sex workers [4.6 (3.6–
6.4)%]; injecting drug users [39.3(29.0–52.7%)]. VCT
services have been established in four hospitals and one
NGO clinic. The standard procedure in these VCT services,
in accordance to WHO guidelines for settings with HIV
prevalence = 10% [16], requires three HIV tests (two rapid
and one Enzyme Immunoassays test). Patients would
have to return the next day to obtain all three test results.
These VCT services are free of charge for all, including TB
patients, through financial support from the Global Fund
to fight AIDS, TB and Malaria.
Study design
The study was conducted in parallel to a HIV prevalence
survey among TB patients carried out between April and
December 2006. The survey targeted TB patients attending
all (88) public and private DOTS services in three out of
five districts in the province. TB patients in participating
health facilities were offered unlinked anonymous HIV
testing for survey purpose and additionally free services of
four hospital-based VCT centres. Nurses provided patients
with standardized information on HIV and VCT services
aided by a brochure which was subsequently given to the
patient. If the patient expressed interest, nurses made an
appointment with a VCT centre and provided an incentive
to cover transport expenses to the centre. Out of 1269 TB
patients whom were offered unlinked anonymous testing
during the survey, 989 (77.9%) accepted [17]. The HIV
prevalence was 1.9% (95% CI 1.6–2.2%) [17]. Out of
these 989 patients, 133 (13.4%) expressed interest in VCT
but only 52 (39.1%) subsequently attended VCT.
The patients were asked whether they would be willing to
be recruited for follow up in-depth interviews. We
grouped the patients who accepted into four groups: (1)
patients who refused unlinked anonymous testing and
expressed no interest in VCT; (2) patients who accepted
unlinked anonymous testing and expressed no interest in
VCT; (3) patients who expressed interest, but did not
attend VCT; and (4) patients who attended VCT. Among
1269 patients offered unlinked anonymous testing and
VCT service during the parallel survey, 764 accepted to be
interviewed. Figure 1 presents the distribution of these
consenting patients by the 4 patient categories. We aimed
to purposively sample eight patients within each group,
keeping in mind the type of health facility attended and
additionally age, gender, education and urban/rural resi-
dency. Appointments were made by nurses for the in-
depth interviews of selected patients.
We interviewed 33 patients: 6 patients for group 1; 16
patients for group 2; 2 patients for group 3; and 9 patients
for group 4. We faced difficulties recruiting patients forBMC Public Health 2008, 8:385 http://www.biomedcentral.com/1471-2458/8/385
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group 3 because the interview was perceived as a blaming
attempt since they had received an incentive to cover
transport to VCT, but had not attended. The large number
of patients in group 2 was due to the need to increase the
number of interviews to make up for the limited informa-
tion collected from the first 8 respondents related to their
very poor knowledge about HIV/AIDS. Patients were
interviewed on the basis of an in-depth interview guide on
why they were interested or not interested in VCT and
probed for factors that hinder or support VCT uptake, e.g.
knowledge, attitudes, information given by health provid-
ers regarding VCT.
Barriers preventing DOTS services providers to offer VCT
services were also explored. We investigated nurses' per-
ceptions through four Focus-Group Discussions (FGDs)
sampling the different health facility types: (1) urban
health centres; (2) rural health centres; (3) private hospi-
tals; and (4) public hospitals and chest clinics. Within
each group, we purposively selected nurses who were
most involved in the offering HIV testing among TB
patients and represented facilities with variation of
patients' interest rate toward HIV testing. Each group con-
sisted of eight to nine nurses. We finally carried out three
in-depth interviews with all the specialist physicians pro-
viding DOTS services in public and private hospitals and
with the three district disease control managers.
The in-depth interviews and FGDs were conducted by the
first and second author.
Data analysis
We recorded and fully transcribed all in-depth interviews
and FGDs. Data analysis was supported using the QSR
N6® software (QSR International Pty. Ltd., Melbourne,
Australia, 2002). The analysis was inductive which
implies that categories of analysis were not imposed a pri-
ori  on the data but are identified through the analysis
process [18]. Transcripts imported into the software data-
base were scrutinized to identify emerging and recurrent
themes and a codebook was progressively established and
structured. Text units were coded systematically. Coding
Patient flow Figure 1
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frequency permitted to identify key issues and trends
regarding perceptions of patients and providers about bar-
riers to HIV testing.
Ethical issues
We safeguarded confidentiality of patients' serostatus by
unlinking HIV test results from our patients' identities.
Informed consent was obtained from all respondents
prior to data collection. All collected data were kept anon-
ymous. Ethical approval for the qualitative data collection
and the HIV-TB prevalence survey was given by the ethical
review committee of the Faculty of Medicine, Gadjah
Mada University, Indonesia.
Results
Patients' characteristics
Table 1 presents the characteristics of the interviewed
patients' for the four categories. There were slightly more
males then females among the patients. In general, they
were predominantly aged between 20–40 years old, mar-
ried, had secondary education and were offered VCT serv-
ices by a public care provider. The groups' characteristics
were in general similar with the exception of group 1 hav-
ing slightly more old patients and group 4 having more
patients attending public health facilities.
Factors influencing patients' interests in VCT
Many of our respondents (22) were not interested to
attend VCT regardless of gender, age, education and mar-
ital status. Most patients (24) had no negative feeling
towards the HIV test offer, though some (9) clearly felt
offended:
Frankly, that time I was offended. From the beginning,
it was already explained that HIV is transmitted by this
and that, not all drug users get it, also not all 'others'
[risk groups] get it. And then all the sudden they
offered me HIV test? 23-year-old, male, university stu-
dent, attended VCT
Knowledge of many respondents (11) on HIV was poor,
ranging from those who had never heard of HIV to those
who knew little. Patients with limited knowledge were
less interested in VCT:
Table 1: Characteristics of enrolled TB patients
Patients' Characteristics Patients' category* Total N (%)
Group 1 N (%) Group 2 N (%) Group 3 N (%) Group 4 N (%)
Gender
Male 4 (66.7) 8 (50.0) 1 (50.0) 5 (55.6) 18 (54.5)
Female 2 (33.3) 8 (50.0) 1 (50.0) 4 (44.4) 15 (45.5)
Age group
15–19 years old 0 (0.0) 0 (0.0) 1 (50.0) 1 (11.1) 2 (6.1)
20–29 years old 2 (33.3) 9 (56.3) 1 (50.0) 4 (44.4) 16 (48.5)
30–39 years old 0 (0.0) 8 (31.3) 0 (0.0) 1 (11.1) 6 (18.2)
40–49 years old 0 (0.0) 2 (12.5) 0 (0.0) 3 (33.3) 5 (15.2)
> 49 years old 4 (66.7) 0 (0.0) 0 (0.0) 0 (0.0) 4 (12.1)
Education
Primary 1 (16.7) 2 (12.5) 0 (0.0) 2 (22.2) 5 (15.2)
Secondary 3 (50.0) 11 (68.8) 0 (0.0) 4 (44.4) 18 (54.5)
Tertiary 2 (33.3) 3 (18.8) 2 (100.0) 3 (33.3) 10 (30.3)
Married
Yes 4 (66.7) 11 (68.8) 1 (50.0) 5 (55.6) 21 (63.6)
No 2 (33.3) 5 (31.3) 1 (50.0) 4 (44.4) 12 (36.4)
Health facility type
Public 3 (50.0) 11 (68.8) 2 (100.0) 8 (88.9) 24 (72.7)
Private 3 (50.0) 5 (31.3) 0 (0.0) 1 (11.1) 9 (27.3)
TOTAL 6 (100.0) 16 (100.0) 2 (100.0) 9 (100.0) 33 (100.0
*Patients category:
• Group 1. Not accepting unlinked anonymous and not interested for VCT.
• Group 2. Accepted unlinked anonymous but not interested for VCT.
• Group 3. Accepted unlinked anonymous, expressed interest but did not attended VCT.
• Group 4. Accepted unlinked anonymous and attended VCT.BMC Public Health 2008, 8:385 http://www.biomedcentral.com/1471-2458/8/385
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The problem is I don't even know what HF [HIV] is. Is
it a new disease? I am just a lay person, so I don't
know. It was my son who replied. [I told him] you
should respond because you are the one who can
answer.  52 year-old, male, employee, not interested in
VCT
Well what can I say? That HIV is not scary. It's just another
disease. It can be cured. 29-year-old, female, employee, not
interested in VCT
Misconceptions regarding transmission of HIV/AIDS were
common:
You can get infected through having a [sexual] rela-
tionship or through drugs or through smoking ciga-
rettes, that's all I know. I heard it before from stories,
you know, on TV. 26-year-old, male, unemployed,
attended VCT
I would imagine, that people who get infected by HIV
are those who keep changing partners. If one doesn't
change partners and does not use illegal drugs, then
probably [he/she] can't get infected. 45-year-old, male,
construction worker, attended VCT
Table 2 summarizes the relations between main patients'
perceptions and VCT interest. Many patients (16) did not
report to perceive themselves at risk, or simply did not
know enough to attribute risk (10):
It's just for a test. It's not because one gets TB that one
will get HIV. I've never done anything [wrong]. So I
don't mind and I am also looking for a new experi-
ence. I am confident that the result will be non-reac-
tive. No worries whatsoever. I am sure, Insya Allah
[God's willing], as the doctor already know, that I
won't get it. I imagine if one gets it. Oh my God! 37-
year-old, male, employee, attended VCT
I mean usually those who get HIV are those who like
to go out at night, they like to...well, like commercial
sex workers, they're like that, so they must get it. I
never go out at night. I hardly leave my house. How
can I get HIV? 29-year-old, female, employee, attended
VCT
A few patients (7) accepted that they could be at risk and
were interested in VCT:
I've never done anything wrong [risky], or had a [sex-
ual] relationship with someone with HIV. I've never
received blood transfusion, never. I don't believe I can
get HIV but, there's a possibility I get it because of TB,
they say that can make you get infected easily. 45-year-
old, male, construction worker, attended VCT
No, I was already told [by the health worker] that from
...from the lungs it can lead to HIV. So I already knew
beforehand. 24-year-old, female, self-employed, attended
VCT
Nearly half of the patients (16) perceived a certain benefit
of HIV testing, regardless of whether they reported to per-
ceive themselves at risk or not. Many of these (9)
expressed interest towards VCT:
Well, to be able to know [whether I get] AIDS or ...HIV.
I was not surprised [to be offered HIV testing]. I
wanted to be examined to see if I had other diseases.
26-year-old, male, unemployed, attended VCT
Some patients (10) perceived some stigmatization
towards people living with HIV in the society. Others (8)
did not perceive stigmatization, while the remaining par-
ticipants (15) had no opinion. Most of those who per-
ceived stigmatization (6) however were interested in VCT:
[They are] afraid to get infected, yes. Also afraid of ...
what else...Well, it's a shameful and horrible disease.
It's terrifying. So I would be afraid to be isolated, to be
treated as someone infectious, as someone who has a
pathetic disease. If I can, I will just avoid such disease.
29-year-old, female, attended VCT
Well, the problem is AIDS is... Well, it is a shameful
disease. I don't know... The problem is most people
who get AIDS are those who do wrong things. People
where I live, if they know, they will avoid you imme-
diately. 17-year-old, female, student, attended VCT
Some patients (5) feared knowing the HIV test result and
were not interested in VCT, or initially expressed interest,
but eventually changed their mind:
Table 2: Patients' perceptions and interest for VCT
Patient's perception Interested for VCT
At risk of being infected Yes majority
No minority
VCT entails benefits Yes roughly half
No small minority
HIV patients are stigmatized Yes roughly half
No minority
Fear of knowing test result Yes small minority
No vast majority
Access to VCT is a burden Yes minority
No vast minorityBMC Public Health 2008, 8:385 http://www.biomedcentral.com/1471-2458/8/385
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Why did it go that far? Saying HIV was like this and
that. That made me scared. It's about psychology, I am
sure I don't have HIV, but I am not mentally ready. It's
enough that I got TB. If for instance I had to be tested
for something like that [HIV], it could make things
more complicated with so many problems...Oohhh!
23-year-old, male, student, not interested in VCT
If they take my blood again, then they will test it, then
if it turns out that I have that disease, it's like being
struck on the head, it's a mental burden. What I am
afraid of is that there is no cure yet, you die because of
HIV. So if there's no treatment you will just die. 23-
year-old male, student, initially expressed interest, but did
not attend VCT
A number of patients (8) also perceived burden for access-
ing and utilizing VCT. Most of these (6) were not inter-
ested in VCT.
The process would become too cumbersome. When I
think about it, it will just make the process longer and
complicated. My intention to seek treatment was just
to get my coughs cured. 25-year-old, male, self-employed,
not interested in VCT
Well, at that time I thought, if they can do it at that
moment, I wouldn't mind. I thought it would take too
much time. [I asked] how I would know the result.
[They said] if I wanted to know I have to go there. How
can I manage the time? 51-year-old, male, employee, not
interested in VCT
Nurses' perceptions
Table 3 depicts the distribution of main issues perceived
by nurses across different type of health facilities. Most
nurses considered their knowledge of HIV-TB insufficient:
At the least, the lab technician, TB worker, nurse and
doctor should know about the HIV issue comprehen-
sively. Sometimes we go for training and bring home
materials, but we don't really read them. There are
patients who really need information on what is the
relevance, goals. Yesterday there were two like that. At
the end I had to read, I had to open the reference for
them. The problem is we ourselves do not understand
HIV comprehensively. Female, nurse, rural health centre
Nurses especially in the hospitals perceived that there are
patients difficult to deal with, for instance skeptical highly
educated patients. Nurses in hospitals also more fre-
quently perceived offended patients as an issue:
Once we had a patient who was a high school teacher.
We discussed how TB is the leading opportunistic
infection for HIV. At the end it became confusing
because the theory was not clear. At the end she
refused. So how can we deal with patients who are
highly educated? Female, nurse, rural health centre
Even though we have explained this and that...but in
the end it doesn't seem to suffice. We really are not
effective. Female, nurse, public hospital
The majority reacts negatively [to the offer]. Patients
feel they have never done any wrongdoings. Patients
feel they could not get it. Especially the VIPs [Very
Important Person – Patients in first class wards]. All
the VIPs refused. Female, nurse, private hospital
Lack of facilities was an issue perceived by nurses of all
types of structures:
The room is still mixed [with other patients]. So, if
possible, a separate room, which would be better to
give patient education. It's inconvenient for us to do it
when there are other patients around. Male, nurse, pub-
lic hospital
We don't have a special room. Our place until now is
semi-permanent, so mixed Maybe it wasn't convenient
to offer the test to the patients under such condition.
Female, nurse, rural health centre
Table 3: Nurses' perceptions of barriers to introduce HIV testing among TB patients*
Perception Health centres Hospitals and chest clinics
Rural Urban Public Private
'Hard' patients - - + ++
Additional burden +/- +/- ++ ++
Patients offended - - ++ ++
Stigmatization + +/- +++ ++
Lack of facility + +++ +/- +
Communication difficulty +/- +/- ++ +++
* "+++" = critical; "++" = very important; "+" = "important"; "+/-" = less important; "-" = negligibleBMC Public Health 2008, 8:385 http://www.biomedcentral.com/1471-2458/8/385
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Nurses at all facilities perceived some burden due to hav-
ing to offer an HIV test, particularly with limited time
available:
We don't have enough staff, for our lung clinic. It's just
me and one assistant. If there are many patients we
really don't have time, really too overwhelmed to offer
[HIV testing]. We have more time in the morning.
Those patients who accepted the offer are usually
those who come in the morning. Female, nurse, private
hospital
Nurses in hospitals particularly perceived difficulties in
communication, mainly when it comes to patients who
are 'hard' to deal with:
If they have detailed questions we have difficulty in
explaining in details. We can handle general ques-
tions, but university students ask a lot of questions
which are beyond our knowledge. Female, nurse, pri-
vate hospital
Stigmatization of people living with HIV/AIDS within the
community was perceived to be a barrier, particularly in
hospitals:
They had fear, what if they turn out to be [HIV] posi-
tive? What would happen when they have to face the
community. Some of them are community leaders.
Female, nurse, private hospital
Strikingly, a few nurses' comments suggested that some
nurses stigmatize people living with HIV:
We're also worried, what if nurses get it too? It will
[then] become very risky for [HIV-negative] patients.
We need to isolate them if we can identify them, but
until now we don't know who is positive and who is
not. Even if it's [just] gonorrhoea and somebody [staff]
knows, everyone [staffs' behaviour] becomes different.
Female, nurse, public hospital
Perceptions of decision makers: specialists and disease 
control managers
Both specialists and disease control managers perceived
patient-provider communication and stigmatization as
important barriers to VCT uptake:
Yes, I've observed that some health workers really can't
talk, they can't communicate. Really, it's not that they
don't want to do it, but they simply don't have the
capacity to do it. So we can't do anything, because they
are all we got. Female, disease control manager, urban dis-
trict
What I liked about the programme [introducing HIV
testing among TB patients] was that the TB patients got
more attention. There was a demand to the health
worker to be able to communicate better. We basically
have nurses and doctors who can communicate well,
but the majority have limited communication skills
and it's not just a matter of education, it's also about
personality. Male, disease control manager, rural district
Specialists seemed to be more optimistic, giving more
emphasis on the managerial challenges than on the oper-
ational:
The most important thing is that this is integrated at
the top level. If this is still under two different national
programmes then it will be difficult for policy making.
If it's integrated at the top level, [we] at the frontline
just have to implement. But if at the top there are still
two heads, what can we do? It's a sensitive issue, but
that's the reality. Male, senior lung specialist, public chest
clinic and private hospital
The management system needs to be repaired. If we're
integrating TB and HIV, the management becomes
more [crucial]. Especially that we're involving two dif-
ferent national programmes together. The financing,
the organization... Male, junior lung specialist, teaching
hospital and private hospital
They also perceived much less additional burden:
I don't feel any [significant] additional burden. As far
as I've observed, care delivery was not disrupted. Of
course there were some additional things [tasks], but
not so much. Male, senior lung specialist, public chest
clinic and private hospital
However, specialists strongly perceived lack of knowledge
on HIV to be a major hindrance to introduce testing,
including among colleagues:
Even in this hospital, other specialists don't really
know [about HIV]. Internal medicine and dermatove-
nereology [specialists] know quite a bit, but others still
ask a lot of questions. They only know it superficially.
Male, internist, private and teaching hospital
But both district control managers and specialists were
not concerned with potential harms to the TB control pro-
gramme's performance:
"No, I am not worried, the patients were not obliged
to be tested ... and I've observed no reduction of case
reporting so far. Our patients were not running away".
Female, disease control manager, urban districtBMC Public Health 2008, 8:385 http://www.biomedcentral.com/1471-2458/8/385
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Discussion
Previous studies examining the motivations and deter-
rents to HIV testing have been carried out mainly among
groups other than TB patients, i.e.: pregnant women
[14,19]; drug users [12,20]; poor population [21]; and
multiple risk groups [13,22]. Our study contributes to the
evolving body of evidence on specific factors that influ-
ence introduction of HIV testing among TB patients. This
study is limited by qualitative research boundaries. Issues
perceived by patients and providers were identified.
Although trends emerge, the respective influence of each
issue was not quantified. This could be documented
through a quantitative survey building on our findings,
which points out the key issues to be taken into account.
We have focused on contrasts between patients who
expressed and did not express interest for VCT because
only two patients who expressed interest but did not
attend could be interviewed (group 3) and because we
interviewed more patients who did not express interest
but accepted unlinked anonymous (group 2). This means
our findings can be interpreted in terms of VCT uptake
rather than interest. Although our findings are context
bound, generalization can be considered to other prov-
inces in Indonesia with similar socio-economic, HIV-TB
epidemiology and health system characteristics. Some
specific findings may hold in similar settings in other
countries.
Knowledge
Knowledge of TB patients on HIV and its transmission was
strikingly poor with considerable misconceptions, partic-
ularly regarding transmission routes. Pregnant women in
Hong Kong and China reportedly also had inadequate
knowledge regarding HIV transmission [14,23]. Poor
knowledge of HIV among the general population in the
US and pregnant women in Hong Kong is associated with
poor uptake of HIV testing [14,22]. In addition, our find-
ings suggest that knowledge of providers regarding HIV
and HIV-TB is also insufficient. A similar lack of knowl-
edge particularly regarding HIV testing among physicians
was documented in India [24,25]. The need for profes-
sional education to precede VCT programmes has also
been further affirmed by a study among health workers in
China [23].
Stigmatization
Our data suggests that stigmatization of HIV is present in
the Indonesian society. HIV/AIDS has been one of the
most stigmatized diseases of the last 20 years [26]. HIV-
associated stigma has remained a barrier to testing among
pregnant women in China [23]. Perceived stigmatization
among mineworkers in South Africa and urban inhabit-
ants in Mali reportedly also deterred them from HIV test-
ing [27,28]. Stigmatization was also considered to be an
important barrier to HIV testing by nurses in our study.
Our findings further show that there are even nurses who
also stigmatize HIV patients. This is similar to the findings
from China in which 30% of health workers would not
treat HIV patients [23]. However, our data suggests that
stigmatization did not play much role on patients VCT
interest. Most likely this is because HIV/AIDS in our set-
ting is not yet a widespread disease with high visibility.
Other factors outweigh stigmatization when it comes to
interest in VCT, e.g. a clear indication of the risk for HIV
infection, as effectively communicated by the care pro-
vider, coupled with patients' concerns for their personal
well-being.
Perceived benefit and risk
Perceived benefit and risk showed considerable influence
on VCT interest among our TB patients. Mineworkers in
South Africa perceive HIV testing to be more acceptable if
antiretroviral therapy (ARVs) become more available [27].
Rates of HIV testing tend to increase as perceived benefits
increase. However, the most worrying HIV testing barrier
is that people do not perceive themselves at risk [29]. The
main stated reason for refusal of HIV screening among TB
patients in Tamilnadu, India was 'no risk behaviour' [30].
Some drug users in the US indeed did not test for HIV as
they had not perceived themselves at risk [12]. Perception
of not being at risk persists as a barrier to testing in the US,
despite self-report of high-risk behaviors [13]. We likewise
encountered a similar tendency among our TB patients.
Fear of knowing the test result
Our findings indicate that fear of knowing test result plays
a role in VCT interest. Such fear has also been documented
as a barrier among risk populations in the US [13]. A sur-
vey among Indonesian drug users in Bali province docu-
mented that the most important reason for avoiding HIV
testing (55% respondents) was fear of positive results
[20]. A qualitative study carried out more recently in the
same risk population affirmed the importance of fear of
knowing the test result as a barrier [31].
Perceived burden for utilizing VCT
In addition to transportation, our patients still had to
spend considerable time waiting for the counselor to see
them, undergo the counseling process, have their blood
taken, return home and come back again the next day for
the result. The length of the process, linked to the percep-
tion of not being at risk, was enough to deter most
patients. Our TB patients were offered transport incen-
tives, but this did not help much. Other studies have doc-
umented similar observations. Some Indonesian drug
users refused testing because of the long wait and compli-
cated procedures [20]. Accessibility of the VCT centres has
been shown to motivate TB patients in India to undergo
testing for HIV [30]. Drug users in the US decided to testBMC Public Health 2008, 8:385 http://www.biomedcentral.com/1471-2458/8/385
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because the site was immediately available and they need
not travel far [12].
Communication
A main barrier from the providers' side was related to
communication. Providers attributed this problem to dif-
ficulties to communicate on HIV issues, lack of time and
adequate facilities. The disease control managers stated
that health workers hardly communicate with patients
and that some health workers did not have proper com-
munication skills. Patient-provider communication
around HIV in resource-constrained setting seemingly
falls short of best-practice standard [25].
Our findings additionally revealed that communication
was influenced by characteristics of the patient, provider
and healthcare facility conditions. The worst case scenario
occurs when a skeptical highly educated patient comes
into contact with a nurse worker with poor communica-
tion skills in an overburdened hospital. This highlights
the need for creating the material conditions in the health
services which make it easier for health workers to interact
with patients. Indonesia's health services were designed to
cope with acute diseases and the existing service delivery
model is clearly not conducive to effective VCT. HIV/AIDS
is a complex chronic condition requiring long-term
involvement, patient-centered approaches and patient-
provider communication starting from the point of HIV
testing offer.
The magnitude of communication problems identified in
this study was not evenly distributed across health facility
types and was more prominent in hospitals especially pri-
vate. These hospitals are overloaded with patients. They
also see more patients who are challenging to deal with.
All of these issues have to be managed under conditions
of limited time, staff and facilities.
Conclusion
TB patients evidently experienced multiple barriers that
can deter them for HIV testing. The study highlighted that
patients' and providers' knowledge regarding HIV was
inadequate in our setting. The main barriers to HIV testing
identified were: fear, burden to access VCT and communi-
cation problems. Stigma exists in society and caused con-
cerns among providers, but did not seem to play much
role in patients' interest in VCT.
If the Ministry of Health intends to move forward with
linked confidential HIV testing among TB patients
through VCT, provider's and patient's knowledge need to
be improved simultaneously, the general healthcare sys-
tem strengthened by providing the necessary conditions
for effective communication and patient-provider interac-
tion and offering VCT at potential DOTS services that can
provide results on the same day. The potential acceptabil-
ity of the alternative PITC model would be worth to
explore further. However, it would clearly require even
more demanding pre-conditions and thus should be
reserved for settings with more advanced HIV epidemic.
In any case, efforts to understand and overcome specific
local barriers must accompany efforts to introduce HIV
testing among TB patients.
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